BioMimetix JV, LLC (United States)
BioMimetix — First-in-Class Metalloporphyrin | Redox Resilience in Oncology
BioMimetix is developing BMX-001, a first-in-class metalloporphyrin SOD mimic with FDA Breakthrough Therapy Designation. Protecting healthy tissue while enhancing tumor response across multiple oncology indications.
Company details
- Address
- United States
- Website
- biomimetixpharma.com
Reviews
No reviews yet.
All reviews of BioMimetix JV, LLC (United States) · Write a review
Domain and WHOIS record
- Domain
- biomimetixpharma.com
- Registrar
- GoDaddy.com, LLC
- Registered
- 26 Apr 2011
- Expires
- 26 Apr 2028
- Record updated
- 27 Apr 2026
- Name servers
- ns71.domaincontrol.com, ns72.domaincontrol.com
- DNSSEC
- Not signed